Conclusion: These findings add to the evidence that clopidogrel monotherapy is superior to aspirin monotherapy for MACCE prevention with no increase in the risk of bleeding, and support the preferential use of clopidogrel over aspirin for secondary prevention in patients with established CAD.
PubMed 40902613 ↗Aspirin
The short answer. People are split on Aspirin — 41% of 32 say it helped. It is most often used for focus: 89% of 9 reports say that improved. It is well studied — 2,128 meta-analyses on PubMed. The most common complaint is stomach issues.
From 112 mentions in total — the rest didn't say how it went and aren't counted.
What Aspirin does, according to users
Of the people who reported each effect, the share who said it got better.
10 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 2,128 meta-analyses on PubMed ↗ · 5,064 randomized trials ↗
Conclusion: Aspirin is associated with a reduction in ASCVD when used for primary prevention; however, it is unlikely to be clinically significant given the increase in bleeding. More importantly, aspirin's treatment effect does not increase as ASCVD risk increases, as many hypothesize. There is no suggestion from these data that use of aspirin for higher-risk primary prevention patients is beneficial.
PubMed 32445718 ↗Conclusion: The use of aspirin in individuals without cardiovascular disease was associated with a lower risk of cardiovascular events and an increased risk of major bleeding. This information may inform discussions with patients about aspirin for primary prevention of cardiovascular events and bleeding.
PubMed 30667501 ↗Conclusion: In individuals with diabetes, aspirin had no effect on nonfatal myocardial infarction (p = 0.93) or cardiovascular death (p = 0.92) and increased the risk of bleeding by 49% (p = 0.13). This meta-analysis suggests that aspirin should not be used on a routine basis in the primary prevention of cardiovascular events, especially in individuals with diabetes.
PubMed 31096304 ↗2,195 human trials on ClinicalTrials.gov test Aspirin — 1,097 completed, 244 recruiting now. See all on ClinicalTrials.gov ↗
- Long-term Effect of Dupilumab in N-ERD · NSAID-Induced Asthma, NSAIDs Hypersensitivity · 2026
- Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP) · Chronic Myeloid Leukemia, Chronic Phase · 2025
- Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement · Pulmonary Embolism, Venous Thrombosis · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
13 recalls of products named for Aspirin. Most recent:
- 2024-11-27 · Class II: cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. record ↗
- 2024-01-03 · Class II: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. record ↗
- 2022-07-27 · Class III: Failed Tablet/Capsule Specification : Capsule breakage record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
534,081 adverse-event reports mention Aspirin. Most often reported:
- Fatigue · 33,155
- Dyspnoea · 28,112
- Diarrhoea · 27,506
- Nausea · 27,443
- Dizziness · 23,142
- Drug ineffective · 22,481
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Aspirin A — a well-established cause of liver injury (more than 50 published cases). LiverTox entry ↗
NIH has funded 175 research projects with Aspirin in the title, $487,371,006 in total (1985–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Aspirin ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Aspirin works better than anything I've ever tried, even cissus or other NSAIDS.”
“Aspirin: Helped circulation but I had to stop taking it due to stomach lining issue”
“Many of us feel some general relief from everyday discomforts with ibuprofen, paracetamol, or aspirin”
“I've noted that a feel a bit better on aspirin but not as strongly as prednisone”
Top discussions (5)
- The Hangover Effect: Feeling Great After Drinking Too Much ↗
- I am going to WAR against my INFLAMMATION. Assist me biohacking brothers. ↗
- Table of Bryan Johnson's Supplements ↗
- Ibuprofen alone increased the relative number of dopaminergic neurons by 47% (+ More For Those Quitting Amphetamine) ↗
- Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production. ↗
Other options for focus
Sources
- User reports: 112 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate